Effect of brincidofovir on adenovirus and A549 cells transcriptome profiles

Maud Salmona1, Linda Feghoul2, Séverine Mercier-Delarue2

  • 1Université de Paris, INSERM U976, Insight Team, F-75010, Paris, France; Assistance-Publique des Hôpitaux de Paris, Microbiology Department, Virology Unit, Saint Louis Hospital, F-75010, Paris, France.

Antiviral Research
|August 10, 2020
PubMed
Abstract

Insights

Brincidofovir (BCV) reduces human adenovirus (HAdV) replication and alters viral gene expression. This antiviral treatment also enhances cellular antiviral pathways, offering new strategies for controlling HAdV infections.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Human adenovirus (HAdV) infections pose significant risks, especially in transplant patients, necessitating effective antiviral therapies.
  • Brincidofovir (BCV), a cytidine analog, is an antiviral agent that inhibits HAdV replication.
  • The precise mechanisms by which BCV impacts host cellular antiviral responses remain incompletely understood.

Purpose of the Study:

  • To investigate the effects of Brincidofovir (BCV) on cellular antiviral pathways in the context of Human Adenovirus (HAdV) infection.
  • To analyze the impact of BCV on the transcriptome of both HAdV-infected and non-infected lung epithelial cells.

Main Methods:

  • RNA sequencing (RNAseq) was employed to assess the cellular and viral transcriptome.
  • A549 lung epithelial cells were infected with HAdV C5 and treated with or without BCV for 72 hours.
  • Bioinformatic analysis, including ontologic analysis, was performed on the obtained transcriptomic data.

Main Results:

  • BCV treatment significantly reduced viral transcription in HAdV-infected cells, with notable changes in early (E1A, E4) and late (L1) gene expression.
  • BCV profoundly impacted the host cell transcriptome, affecting pathways like mTOR signaling and Wnt pathways.
  • BCV treatment inhibited the biological function of viral replication and modulated 25 genes involved in inflammation.

Conclusions:

  • Brincidofovir (BCV) demonstrably alters viral gene expression and upregulates cellular antiviral pathways in lung epithelial cells.
  • These findings provide novel insights into targeting cellular pathways for the effective control of Human Adenovirus (HAdV) infections.

Related Concept Videos

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
540
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
362
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
14.4K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.5K